Mesenchymal stromal cell characteristics vary depending on their origin

Stem Cells and Development

Volumn 22, Issue 19, 2013, Pages 2606-2618

  Wegmeyer, Heike ^a   Bröske, Ann Marie ^a   Leddin, Mathias ^a   Kuentzer, Karin ^a   Nisslbeck, Anna Katharina ^a   Hupfeld, Julia ^a   Wiechmann, Kornelius ^a   Kuhlen, Jennifer ^a   Von Schwerin, Christoffer ^a   Stein, Carsten ^a   Knothe, Saskia ^a   Funk, Jürgen ^b   Huss, Ralf ^a,c   Neubauer, Markus ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Apceth GmbH and Co KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGE DISTRIBUTION; AMNION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL LINEAGE; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO MEMBRANE; FETUS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MESENCHYMAL STROMA CELL; NERVE CELL DIFFERENTIATION; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION; UMBILICAL CORD;

AMNION; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KARYOTYPE; MESENCHYMAL STROMAL CELLS; PLACENTA; PREGNANCY; REGENERATION; UMBILICAL CORD;

EID: 84884539106     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0016     Document Type: Article

References (69)

1. Parekkadan B and JM Milwid. (2010). Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87-117.
2. Huss R. (2010). Stem cell therapeutics: Hope for patients and biopharma! Stem Cells Dev 19:593-594.
3. Sensebe L, M Krampera, H Schrezenmeier, P Bourin and R Giordano. (2010). Mesenchymal stem cells for clinical application. Vox Sang 98:93-107.
4. Singer NG and AI Caplan. (2011). Mesenchymal stem cells: Mechanisms of inflammation. Annu Rev Pathol Mech Dis 6:457-478.
5. Bianco P, X Cao, PS Frenette, JJ Mao, PG Robey, PJ Simmons and CY Wang. (2013). The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine. Nat Med 19:35-42.
6. Le Blanc K and D Mougiakakos. (2012). Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 12:383-396.
7. Crisan M, S Yap, L Casteilla, CW Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
8. da Silva ML, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213.
9. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
10. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228.
11. Kucia M, M Halasa, M Wysoczynski, M Baskiewicz-Masiuk, S Moldenhawer, E Zuba-Surma, R Czajka,WWojakowski, B Machalinski and MZ Ratajczak. (2007). Morphological and molecular characterization of novel population of CXCR4 + SSEA-4 + Oct-4 + very small embryonic-like cells purified from human cord blood: Preliminary report. Leukemia 21:297-303.
12. Seshareddy K, D Troyer and ML Weiss. (2008). Method to isolate mesenchymal-like cells from Whartońs jelly of umbilical cord. Methods Cell Biol 86:101-119.
13. Ińt Anker PS, SA Scherjon, KC Kleijburg-van der, WA Noort, FH Claas, R Willemze, WE Fibbe and HH Kanhai. (2003). Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548-1549.
14. Cargnoni A, L Gibelli, A Tosini, PB Signoroni, C Nassuato, D Arienti, G Lombardi, A Albertini, GS Wengler and O Parolini. (2009). Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 18:405-422.
15. Ilancheran S, Y Moodley and U Manuelpillai. (2009). Human fetal membranes: A source of stem cells for tissue regeneration and repair?. Placenta 30:2-10.
16. Prockop DJ and JY Oh. (2012). Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem 113:1460-1469.
17. Prockop DJ. (2009). Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol Ther 17:939-946.
18. Dominici M, BK Le, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
19. Baksh D, R Yao and RS Tuan. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392.
20. Kern S, H Eichler, J Stoeve, H Klueter and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.
21. Barlow S, G Brooke, K Chatterjee, G Price, R Pelekanos, T Rossetti, M Doody, D Venter, S Pain, K Gilshenan and K Atkinson. (2008). Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 17:1095-1107.
22. Bieback K, S Kern, A Kocaomer, K Ferlik and P Bugert. (2008). Comparing mesenchymal stromal cells from different human tissues: Bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng 18:S71-S76.
23. Marongiu F, R Gramignoli, Q Sun, V Tahan, T Miki, K Dorko, E Ellis and SC Strom. (2010). Isolation of amniotic mesenchymal stem cells. Curr Protoc Stem Cell Biol 12:1E.5.1-1E.5.11.
24. Kita K, GG Gauglitz, TT Phan, DN Herndon and MG Jeschke. (2010). Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev 19:491-501.
25. Bianco P, SA Kuznetsov, M Riminucci and P Gehron Robey. (2006). Postnatal skeletal stem cells. Methods Enzymol 419:117-148.
26. Sarugaser R, D Lickorish, D Baksh, MM Hosseini and JE Davies. (2005). Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23:220-229.
27. Parolini O, F Alviano, GP Bagnara, G Bilic, HJ Buhring, M Evangelista, S Hennerbichler, B Liu, M Magatti, et al. (2008). Concise review: Isolation and characterization of cells from human term placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells. Stem Cells 26:300-311.
28. Bourin P, M Gadelorge, JA Peyrafitte, S Fleury-Cappellesso, M Gomez, C Rage and L Sensebe. (2008). Mesenchymal progenitor cells: Tissue origin, isolation and culture. Transfus Med Hemotherapy 35:160-167.
29. Kuznetsov SA, MH Mankani, P Bianco and PG Robey. (2009). Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res 2:83-94.
30. Meisner LF and JA Johnson. (2008). Protocols for cytogenetic studies of human embryonic stem cells. Methods 45: 133-141.
31. Lee RH, MJ Seo, AA Pulin, CA Gregory, J Ylostalo and DJ Prockop. (2009). The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. Blood 113:816-826.
32. Moll G, I Rasmusson-Duprez, L von Bahr, AM Connolly-Andersen, G Elgue, L Funke, OA Hamad, H Lonnies, PU Magnusson, et al. (2012). Are therapeutic human mesenchymal stromal cells compatible with human blood?. Stem Cells 30:1565-1574.
33. Crisan M, CW Chen, M Corselli, G Andriolo, L Lazzari and B Peault. (2009). Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci 1176:118-123.
34. Deasy BM, RC Schugar, SM Chirieleison, KE Wescoe, BT Schmidt, Y Askew, JJ Nance, JM Evron and B Peault. (2009). High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol 2009: 789526.
35. Delorme B, J Ringe, N Gallay, YL Vern, D Kerboeuf, C Jorgensen, P Rosset, L Sensebe, P Layrolle, T Hapupl and P Charbord. (2008). Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 111:2631-2635.
36. Buhring HJ, VL Battula, S Treml, B Schewe, L Kanz and W Vogel. (2007). Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 1106:262-271.
37. Kozanoglu I, C Boga, H Ozdogu, O Sozer, E Maytalman, AC Yazici and FI Sahin. (2009). Human bone marrow mesenchymal cells express NG2: Possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification. Cytotherapy 11:527-533.
38. Chacko SM, S Ahmed, K Selvendiran, ML Kuppusamy, M Khan and P Kuppusamy. (2010). Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol 299:C1562-C1570.
39. Son BR, LA Marquez-Curtis, M Kucia, M Wysoczynski, AR Turner, J Ratajczak, MZ Ratajczak and A Janowska-Wieczorek. (2006). Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factorc-met axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264.
40. Ishige I, T Nagamura-Inoue, MJ Honda, R Harnprasopwat, M Kido, M Sugimoto, H Nakauchi and A Tojo. (2009). Comparison of mesenchymal stem cells derived from arterial, venous, and Whartońs jelly explants of human umbilical cord. Int J Hematol 90:261-269.
41. Gaudino G, A Follenzi, L Naldini, C Collesi, M Santoro, KA Gallo, PJ Godowski and PM Comoglio. (1994). RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J 13:3524-3532.
42. Zambidis ET, TS Park, W Yu, A Tam, M Levine, X Yuan, M Pryzhkova and B Peault. (2008). Expression of angiotensinconverting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112:3601-3614.
43. Kuci S, Z Kuci, H Kreyenberg, E Deak, K Putsch, S Huenecke, C Amara, S Koller, E Rettinger, et al. (2010). CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftmentpromoting properties. Haematologica 95:651-659.
44. Mariotti E, P Mirabelli, G Abate, M Schiattarella, P Martinelli, G Fortunato, NR Di and VL Del. (2008). Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d, and CD56 make a difference. Stem Cells Dev 17:1039-1041.
45. Chang CJ, ML Yen, YC Chen, CC Chien, HI Huang, CH Bai and BL Yen. (2006). Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 24:2466-2477.
46. Deuse T, M Stubbendorff, K Tang-Quan, N Phillips, MA Kay, T Eiermann, TT Phan, HD Volk, H Reichenspurner, RC Robbins and S Schrepfer. (2011). Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20:655-667.
47. Ortiz LA, M DuTreil, C Fattman, AC Pandey, G Torres, K Go and DG Phinney. (2007). Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 104:11002-11007.
48. da Silva Meirelles L, AM Fontes, DT Covas and AI Caplan. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419-427.
49. Newman RE, D Yoo, MA LeRoux and A nilkovitch-Miagkova. (2009). Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 8:110-123.
50. Soncini M, E Vertua, L Gibelli, F Zorzi, M Denegri, A Albertini, GS Wengler and O Parolini. (2007). Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1:296-305.
51. Junker JP, P Sommar, M Skog, H Johnson and G Kratz. (2010). Adipogenic, chondrogenic and osteogenic differentiation of clonally derived human dermal fibroblasts. Cells Tissues Organs 191:105-118.
52. Jones S, N Horwood, A Cope and F Dazzi. (2007). The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 179:2824-2831.
53. Pratama G, V Vaghjiani, JY Tee, YH Liu, J Chan, C Tan, P Murthi, C Gargett and U Manuelpillai. (2011). Changes in culture expanded human amniotic epithelial cells: Implications for potential therapeutic applications. PLoS One 6:e26136.
54. Magatti M, MS De, E Vertua, L Gibelli, GS Wengler and O Parolini. (2008). Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 26:182-192.
55. BartholomewA,C Sturgeon,MSiatskas, KFerrer,KMcIntosh, S Patil, W Hardy, S Devine, D Ucker, et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
56. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
57. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736.
58. Li CD, WY Zhang, HL Li, XX Jiang, Y Zhang, PH Tang and N Mao. (2005). Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Cell Res 15:539-547.
59. Ji YR, ZX Yang, ZB Han, L Meng, L Liang, XM Feng, SG Yang, Y Chi, DD Chen, YW Wang and ZC Han. (2012). Mesenchymal stem cells support proliferation and terminal differentiation of B cells. Cell Physiol Biochem 30:1526-1537.
60. Magatti M, S De Munari, E Vertua, C Nassauto, A Albertini, GS Wengler and O Parolini. (2009). Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant 18:899-914.
61. Liu KJ, CJ Wang, CJ Chang, HI Hu, PJ Hsu, YC Wu, CH Bai, HK Sytwu and BL Yen. (2011). Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes. Cell Transplant 20:1721-1730.
62. Wolbank S, A Peterbauer, M Fahrner, S Hennerbichler, M van Griensven, G Stadler, H Redl and C Gabriel. (2007). Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13:1173-1183.
63. Yoo KH, IK Jang, MW Lee, HE Kim, MS Yang, Y Eom, JE Lee, YJ Kim, SK Yang, et al. (2009). Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259:150-156.
64. Nauta AJ, AB Kruisselbrink, E Lurvink, R Willemze and WE Fibbe. (2006). Mesenchymal stem cells inhibit generation and function of both CD34 + -derived and monocyte-derived dendritic cells. J Immunol 177:2080-2087.
65. Akiyama K, C Chen, D Wang, X Xu, C Qu, T Yamaza, T Cai, W Chen, L Sun and S Shi. (2012). Mesenchymal-stem-cellinduced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell 10:544-555.
66. Tondreau T, L Lagneaux, M Dejeneffe, M Massy, C Mortier, A Delforge and D Bron. (2004). Bone marrow-derived mes-enchymal stem cells already express specific neural proteins before any differentiation. Differentiation 72:319-326.
67. Takashima Y, T Era, K Nakao, S Kondo, M Kasuga, AG Smith and S Nishikawa. (2007). Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129:1377-1388.
68. Morikawa S, Y Mabuchi, K Niibe, S Suzuki, N Nagoshi, T Sunabori, S Shimmura, Y Nagai, T Nakagawa, H Okano and Y Matsuzaki. (2009). Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun 379:1114-1119.
69. Guleria I and MH Sayegh. (2007). Maternal acceptance of the fetus: True human tolerance. J Immunol 178:3345-3351.